Workflow
溢多利(300381) - 溢多利调研活动信息
VTRVTR(SZ:300381)2022-12-04 10:50

Company Overview - Guangdong Yiduoli Biotechnology Co., Ltd. is an innovative biotechnology company primarily engaged in the research, production, and sales of biological enzyme preparations, steroid hormone raw materials, and functional feed additives [3][4]. - The company is the first specialized producer of biological enzyme preparations in China and has become the largest manufacturer and service provider in Asia [3][4]. Product Categories - Biological Enzyme Preparations: The company has expanded its product range from feed enzymes to energy enzymes, food enzymes, paper-making enzymes, textile enzymes, and environmental enzymes [3][4]. - Steroid Hormone Raw Materials: The company has become a significant supplier in the global steroid hormone raw materials industry, focusing on technological innovation in key intermediates [4]. - Functional Feed Additives: The company offers alternatives to antibiotic feed additives, leveraging nearly 30 years of experience in the agricultural and animal husbandry sectors [4][5]. Financial Performance - The net profit for the first half of 2020 is expected to increase by 70%-90% compared to the same period last year, with an estimated profit of approximately CNY 66.54 million to CNY 74.37 million [4][5]. - The growth is attributed to increased demand for steroid hormone raw materials due to the COVID-19 pandemic, as well as the implementation of a ban on growth-promoting antibiotics in feed starting July 1, 2020 [4][5]. Market Opportunities - The company aims to capture the growing market for antibiotic alternatives, particularly in light of new regulations prohibiting certain feed additives [4][6]. - The company’s flagship product, a natural plant extract, has been recognized in overseas markets for its effectiveness and is positioned to take advantage of the domestic market following the ban on antibiotic feed additives [6][7]. Future Plans - The company plans to enhance its production capacity for its flagship antibiotic alternative product and expand its market presence [6][7]. - It aims to strengthen its position in the biological enzyme market by increasing production capacity and diversifying its product offerings [7][8].